BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
SLC12A1
,
nitric oxide metabolic process
,
Arthritis
,
Breast
,
Autoimmunity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
bezafibrate
Summary
General Info
Curated Studies
Most Correlated Studies
Liver Pharmacology and Xenobiotic Response Repertoire
Diverse liver drug signatures
Identification of biomarkers distinguishing chemical contaminants using rat hepatocytes
Neural progenitors from induced pluripotent stem cells stimulated with idebenon and bezafibrate
Hearts of rats exposed variety of toxicants
Explore Curated Studies Results
Literature
Most Relevant Literature
Bezafibrate for X-linked adrenoleukodystrophy.
Square-wave voltammetric determination of bezafibrate in pharmaceutical formulations using a cathodi…
Bezafibrate can be a new treatment option for mitochondrial fatty acid oxidation disorders: evaluati…
Bezafibrate maintenance therapy in patients with advanced chronic hepatitis C.
Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursod…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of Bezafibrate in Mitochondrial Myopathy
Bezafibrate for Hyperfibrinogenemia in Acute Myocardial Infarction
Bezafibrate Trial in CPT2 Deficiency
Bezafibrate Plus Berberine in Mixed Dyslipidemia
Bezafibrate in Patients With Primary Biliary Cholangitis (PBC)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ